Stock VRAX VIRAX BIOLABS GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Market Closed - Nasdaq
Other stock markets
 02:00:01 18/05/2024 am IST 		5-day change 1st Jan Change
0.8395 USD +7.13% Intraday chart for Virax Biolabs Group Limited +4.94% -42.50%
25/04 Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 CI
12/01 Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VIRAX BIOLABS GROUP LIMITED Stock Virax Biolabs Group Limited
 19.83L - - - - -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 4.21TCr
LONZA GROUP AG Stock Lonza Group AG
 4.2TCr
CELLTRION, INC. Stock Celltrion, Inc.
 2.92TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 2.6TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 1.89TCr -
  1. Stock Market
  2. Equities
  3. VRAX Stock
  4. Charts Virax Biolabs Group Limited
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW